Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma. | Neurooncol Adv | 2023 | 37152812 | PubTator, text mining | PubMed |
| The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis. | Front Med (Lausanne) | 2023 | 37144036 | PubTator, text mining | PubMed |
| Deficiencies and Dysregulation of STAT Pathways That Drive Inborn Errors of Immunity: Lessons from Patients and Mouse Models of Disease. | J Immunol | 2023 | 37126806 | PubTator, text mining | PubMed |
| Immunotherapy in glioblastoma treatment: Current state and future prospects. | World J Clin Oncol | 2023 | 37124134 | PubTator, text mining | PubMed |
| Immune exposure: how macrophages interact with the nucleus pulposus. | Front Immunol | 2023 | 37122738 | PubTator, text mining | PubMed |
| The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma. | Pharmaceutics | 2023 | 37111620 | PubTator, text mining | PubMed |
| Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications. | Life (Basel) | 2023 | 37109432 | PubTator, text mining | PubMed |
| Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models. | Int J Mol Sci | 2023 | 37108788 | PubTator, text mining | PubMed |
| The Role of TGF-β3 in Radiation Response. | Int J Mol Sci | 2023 | 37108775 | PubTator, text mining | PubMed |
| Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma. | Cancer Res | 2023 | 37101376 | PubTator, text mining | PubMed |
| Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. | J Immunother Cancer | 2023 | 37100458 | PubTator, text mining | PubMed |
| Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma. | Int J Surg | 2023 | 37093067 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer. | Front Oncol | 2023 | 37091166 | PubTator, text mining | PubMed |
| Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy. | Front Med (Lausanne) | 2023 | 37064017 | PubTator, text mining | PubMed |
| Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps. | Front Immunol | 2023 | 37063895 | PubTator, text mining | PubMed |
| Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors. | Biomed Pharmacother | 2023 | 37062216 | PubTator, text mining | PubMed |
| Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn's Disease. | J Clin Med | 2023 | 37048779 | PubTator, text mining | PubMed |
| CAR T Cell Therapy: A Versatile Living Drug. | Int J Mol Sci | 2023 | 37047272 | PubTator, text mining | PubMed |
| Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. | Int J Mol Sci | 2023 | 37047231 | PubTator, text mining | PubMed |
| Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). | Cancers (Basel) | 2023 | 37046777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=21